Envoy Medical, Inc.
COCH· Nasdaq
COCHEnvoy Medical, Inc.
Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001104659-22-118526
| Metric | Q3 2022 | Q3 2021 |
|---|---|---|
| Revenue | $57.00K | — |
| Net Income | -$1.34M | $5.57M |
| EPS Diluted | -$0.13 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end
